Virtus ETF Advisers’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Virtus ETF Advisers’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,538	Closed	-$56K	–	484
2022 Q1	$56K	Sell	13,538 -808	-6%	-$4.28K	0.03%	363
2021 Q4	$184K	Sell	14,346 -6,491	-31%	-$71.9K	0.07%	238
2021 Q3	$225K	Sell	20,837 -1,093	-5%	-$9.95K	0.1%	241
2021 Q2	$200K	Buy	+21,930	New	+$203K	0.08%	349
2019 Q4	–	Sell	-25,698	Closed	-$222K	–	517
2019 Q3	$222K	Sell	25,698 -1,432	-5%	-$14.5K	0.04%	230
2019 Q2	$302K	Buy	+27,130	New	+$310K	0.06%	208

Other funds holding GRTS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Virtus ETF Advisers's GRTS Position: Q2 2022 in Review

Virtus ETF Advisers sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2022, closing a stake of 13,538 shares — an estimated $56K sold.

Virtus ETF Advisers first reported a position in GRTS in Q2 2019 and held it in 6 quarters. The position peaked at $302K in Q2 2019. 87 funds tracked by Wall St. Rank hold GRTS as of Q2 2022.

Virtus ETF Advisers reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Virtus ETF Advisers sold 13,538 Gritstone bio, Inc. Common Stock shares in Q2 2022, an estimated $56K.
Virtus ETF Advisers first reported a position in Gritstone bio, Inc. Common Stock in Q2 2019 and held it in 6 quarters.
Virtus ETF Advisers's Gritstone bio, Inc. Common Stock position peaked at $302K in Q2 2019.
87 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2022.

Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.